Compare Mesoblast Limited (MESO) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs United States Natural Gas Fund — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.16B), while United States Natural Gas Fund trades at $10.19. The key difference: Mesoblast Limited is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| MESO | UNG | |
|---|---|---|
Market Cap | $2.16B | — |
Sector | Technology | Commodities - Energy |
52-Week High | $20.96 | $16.90 |
52-Week Low | $12.88 | $9.63 |
Enterprise Value | $2.17B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $15.94, up 2.05% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Ryoncil net revenues of $36 million for Q2 2026 (GlobeNewsWire, July 29, 2026), showing commercial traction, yet fundamentals reveal a net loss of -$102.14 million in 2025 with a negative net margin. Valuation metrics include a P/S of 30.52 and P/B of 3.76, indicating high growth expectations.
Outlook hinges on Ryoncil's expansion and pipeline progress, but risks include sustained losses and regulatory hurdles. Analysts are cautiously optimistic with 45% buy ratings, yet the stock faces volatility from earnings misses and high cash burn.
UNG trades at $9.74, up 1.14% in the last 24 hours, amid bearish technical signals from moving averages and oscillators. The stock lacks key financial ratio data, but news highlights natural gas futures volatility and comparisons with equity-based ETFs like FCG. Recent articles from WSJ and Reuters (June 2026) note steady trading ranges and record supply-demand forecasts from the EIA, influencing sentiment.
Outlook remains cautious due to technical weakness and commodity price dependence. Risks include geopolitical tensions and weather-driven demand shifts. Opportunities may arise from LNG demand growth, but investors face high volatility without clear fundamental anchors from traditional ratios.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
